Biotech | August 05, 2021
Novavax signs agreement with European Commission for COVID19 vaccine
Deal for 100 million doses with additional 100 million through 2023
Deal for 100 million doses with additional 100 million through 2023
AstraZeneca, Sinopharm and Moderna were part of the study
Takeda Will Focus its Efforts on Dengue, Zika and Pandemic vaccines
The first six batches are being shipped to the Gamaleya Center, Moscow for the quality approval
The companies anticipate clinical studies to begin in August, subject to regulatory approvals
The said batches have successfully passed all the checks for quality parameters both at the Gamaleya Center in Russia and at the Central Drug Laboratory, Kasauli in India
Entered into a manufacturing partnership with Ocugen, Inc. for manufacturing of COVID-19 vaccine COVAXIN for the US and Canadian markets
The Prime Minister announced that 21st June onwards, the Government of India will provide free vaccines to all Indian citizens above 18 years of age
These vaccine doses will be manufactured and stockpiled by the company from August-December 2021
Production line at Lonza’s site in Geleen will complement the existing production network and support the manufacture of up to an additional 300 million doses per year
Subscribe To Our Newsletter & Stay Updated
